Gayatri BioOrganics Ltd
₹8.00▲ +0.00 (+0.00%)
GAYATRIBI·BSE·Chemicals
Market Cap
63.03 Cr
PE Ratio
-65.50
Volume
8,701
Day High - Low
8.20 - 7.84
52W High-Low
20.25 - 6.25
₹8.00▲ +0.00 (+0.00%)
Market Cap63.03 Cr
PE Ratio-65.50
Volume8,701
Day High - Low8.20 - 7.84
52W High-Low20.25 - 6.25
Gayatri BioOrganics Ltd (GAYATRIBI): company summary
The company's business is deteriorating, with annual revenue swinging from a profit of ₹0 crore to a loss of ₹1 crore and annual net profit widening from a loss of ₹1 crore to a loss of ₹1 crore.
Gayatri BioOrganics Ltd (GAYATRIBI) is a micro-cap Chemicals company valued at ₹63 crore operating in Commodity Chemicals on the NSE and BSE.
- Recent price move
- Gayatri BioOrganics Ltd last traded at ₹8, unchanged on the day.
- Recent developments
- On 2026-09-30, promoter holding was reported at 21.59%. On 2026-06-30, the latest quarter ended with a revenue of ₹2 crore and a net profit loss of ₹0 crore. On 2026-03-31, the previous quarter ended with a revenue loss of ₹0 crore and a net profit loss of ₹0 crore.
- Financial performance
- The company's business is deteriorating, with annual revenue swinging from a profit of ₹0 crore to a loss of ₹1 crore and annual net profit widening from a loss of ₹1 crore to a loss of ₹1 crore. The latest quarter shows a net profit loss of ₹0 crore, which narrowed from a loss of ₹0 crore in the same quarter a year earlier.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -1.67 times book value.
- Things to watch
- The company reported a net loss of ₹1 crore in its latest financial year. The latest quarter ended with a net profit loss of ₹0 crore. Domestic institutional holding fell by 0.15 points in the quarter.
- Where it stands
- The company stands at a net loss of ₹1 crore for the latest financial year, with the latest quarter showing a net profit loss of ₹0 crore. The most significant reported figure is the net loss of ₹1 crore.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
3.4/10
Poor
Fair Value
Sign in to see
ROE
2.02%
Weak
P/E
-65.50x
Loss-making
Debt / Equity
—
Industry
Chemicals
Commodity Chemicals
Overall View
Poor
Price performance
Day₹7.84
₹8.20
52W₹6.25
₹20.25
DocStoX take
Supported by risk (7.2), but held back by momentum (0.0). Scored on 3 of 5 measures.
DocStoX score
Low confidence3.4
/10
Poor
Quality
Weak
ROE 2.0%
Valuation
No data
Loss-making — no meaningful P/E
Growth
No data
No multi-year history
Risk
Moderate
D/E -1.00
Momentum
Weak
13% of 52-week range
Scored on 3 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹63 Cr
52W High / Low
₹20 / ₹6
Dividend Yield
0.00%
Promoter Holding
21.59%
EPS (TTM)
₹-0.14
Book Value
—
Key highlights
- Healthy net margin (173%)
- Low leverage — D/E -1.00
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
2 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Commodity Chemicals
Explore Gayatri BioOrganics Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Gayatri BioOrganics Ltd peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Gayatri BioOrganics Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing